Guest
Guest
Feb 12, 2026
12:42 AM
|
Malegra?120 itself does not have dedicated clinical trials published under that specific brand name. What does exist are clinical trials and large studies of sildenafil citrate (the same active ingredient in Malegra?120) for erectile dysfunction (ED), and regulatory decisions typically rely on this broader sildenafil evidence. Malegra?120 = Sildenafil Citrate generic Malegra?120 is a generic product containing sildenafil citrate, the same active molecule used in the original branded drug Viagra for treating erectile dysfunction. Because it is a generic, manufacturers usually do not conduct new efficacy clinical trials if they can show bioequivalence to an Malegra 120 Mg sildenafil product (like Viagra). Regulators accept the existing clinical evidence on sildenafil citrate’s safety and effectiveness instead. Clinical evidence for sildenafil (the active ingredient) Although there aren’t trials specifically titled “Malegra?120 clinical trials,” the clinical profile of sildenafil includes: A. Large placebo?controlled ED trials Sildenafil has been studied in 21+ randomized, double?blind, placebo?controlled clinical trials (up to 6 months) involving over 3,000 men with erectile dysfunction. These evaluated 25?mg, 50?mg, and 100?mg doses and showed significant improvements in the ability to achieve and maintain erections vs placebo. B. Meta?analyses of multiple trials Systematic reviews and meta?analyses have compiled results from many randomized controlled trials of sildenafil in ED — showing consistent efficacy and safety across populations. C. Bioequivalence studies Many generic formulations are tested in bioequivalence studies in healthy volunteers to confirm they perform similarly to the reference product (e.g., Viagra) in terms of blood levels and safety.
|
